CVS HEALTH Corp CVS

Currently 2 bullish, 1 bearish — stable.

Analysts are holding steady at 2 bullish to 1 bearish.

3 YouTube analysts cover CVS HEALTH Corp (CVS).

3 analysts have covered CVS so far…

Analyst opinions

OptionsPlay45d ago

BULL$CVS

high-volume breakout warrants pullback entry

CVS is worth watching after a high-volume breakout to new highs, with a statistically stretched run suggesting a better entry on a pullback into the mid-80s rather than chasing immediately.

CVS broke out to new highs on elevated volume, but the statistically stretched run suggests waiting for a pullback into the mid-80s rather than chasing the immediate move. The retail healthcare breakout remains intact; patience on entry is the discipline.

Publish-day $92.22 · 05/11

"Which Trade Setups Still Deserve Focus This Week?"

Learn to Invest - Investors Grow58d ago

BULL$CVS

HIMS adds diversification without replacing existing position

CVS is already a small position in the portfolio, and the manager views HIMS as a complementary healthcare holding that improves diversification rather than replacing CVS.

The portfolio manager treats HIMS as a complementary healthcare holding alongside a small existing CVS position, improving sector diversification rather than concentrating further in pharmacy services. Both are held simultaneously as distinct expressions of healthcare exposure.

Publish-day $80.98 · 04/28

"My Investment Portfolio Update 2026"

Stock Moe83d ago

BEAR$CVS

Fibonacci target near 77 with puts

I'm watching CVS and expect a downside toward the 61.8% Fibonacci retracement near 77, so I'm positioning with short-dated puts (and a few calls) while waiting for a 5/13 moving-average confirmation.

CVS is tracked toward the 61.8% Fibonacci retracement near 77, with short-dated puts positioned ahead of a 5/13 moving-average confirmation signal. The technical setup frames downside as the higher-probability near-term outcome.

Publish-day $73.49 · 04/03Target $77.003mo

"XRP ‼️ (IT IS HAPPENING TODAY!)"

No official filings surfaced for CVS yet.